We are live on ! Find out more
FIA

FNY Investment Advisers Portfolio holdings

AUM $278M
1-Year Est. Return 98.99%
This Fund
S&P 500
This Quarter Est. Return
+17.25%
1 Year Est. Return
+98.99%
3 Year Est. Return
+307.32%
5 Year Est. Return
+396.61%
10 Year Est. Return
–
AUM
$354M
AUM Growth
+$43.2M
Cap. Flow
+$30.3M
Cap. Flow %
8.54%
Top 10 Hldgs %
31.72%
Holding
1,674
New
354
Increased
213
Reduced
237
Closed
746

Top Buys

Rank Stock Value
1
CDTX
Cidara Therapeutics
CDTX
+$23.5M
2
BMO icon
Bank of Montreal
BMO
+$13.2M
3
MPWR icon
Monolithic Power Systems
MPWR
+$10.1M
4
SILJ icon
Amplify Junior Silver Miners ETF
SILJ
+$9.5M
5
COPX icon
Global X Copper Miners ETF NEW
COPX
+$8.61M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$15.8M
2
SBSW icon
Sibanye-Stillwater
SBSW
+$4.39M
3
MSFT icon
Microsoft
MSFT
+$3.76M
4
SGML icon
Sigma Lithium
SGML
+$3.53M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$3.36M

Sector Composition

Rank Sector Weight
1 Healthcare 20.04%
2 Financials 17.75%
3 Technology 15.74%
4 Industrials 7.52%
5 Consumer Discretionary 5.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVO
326
Novo Nordisk
NVO
$205B
$106K 0.03%
+2,100
New +$107K
CAEP
327
DELISTED
Cantor Equity Partners III
CAEP
$106K 0.03%
10,400
-1,597
-13% -$16.6K
BLCO icon
328
Bausch + Lomb
BLCO
$6.06B
$105K 0.03%
6,200
– –
CRTO icon
329
Criteo S.A. Ordinary Shares
CRTO
$915M
$105K 0.03%
+5,100
New +$106K
ENB icon
330
Enbridge
ENB
$112B
$105K 0.03%
2,200
+1,800
+450% +$85.9K
MESHU
331
Meshflow Acquisition Corp Units
MESHU
$303M
$105K 0.03%
+10,500
New +$105K
CRDO icon
332
Credo Technology Group
CRDO
$49.6B
$104K 0.03%
727
+591
+435% +$90.9K
NEUP
333
Neuphoria Therapeutics
NEUP
$20.7M
$102K 0.03%
+26,500
New +$188K
FTV icon
334
Fortive
FTV
$18.7B
$101K 0.03%
1,830
-20
-1% -$1.04K
IMVT icon
335
Immunovant
IMVT
$8.64B
$101K 0.03%
4,000
+2,000
+100% +$44.6K
SGRY icon
336
Surgery Partners
SGRY
$1.99B
$100K 0.03%
6,500
-3,729
-36% -$68.5K
PDI icon
337
PIMCO Dynamic Income Fund
PDI
$7.33B
$99K 0.03%
5,600
– –
LION icon
338
Lionsgate Studios
LION
$3.49B
$99K 0.03%
10,888
-50,761
-82% -$361K
LUNR icon
339
Intuitive Machines
LUNR
$2.82B
$95K 0.03%
+5,901
New +$68.3K
LUV icon
340
Southwest Airlines
LUV
$22B
$95K 0.03%
2,300
+2,286
+16,329% +$79.9K
TTSH
341
DELISTED
Tile Shop Holdings
TTSH
$94K 0.03%
+26,800
New +$162K
FIG
342
Figma
FIG
$14B
$93K 0.03%
+2,500
New +$113K
PCVX icon
343
Vaxcyte
PCVX
$8.76B
$92K 0.03%
2,000
– –
SIMO icon
344
Silicon Motion
SIMO
$8.45B
$92K 0.03%
1,000
-1,014
-50% -$93K
RPTX
345
DELISTED
Repare Therapeutics
RPTX
$91K 0.03%
+35,000
New +$70.5K
SUNC
346
SunocoCorp LLC
SUNC
$3.89B
$91K 0.03%
+1,850
New +$93.2K
TTD icon
347
Trade Desk
TTD
$6.84B
$90K 0.03%
+2,378
New +$105K
MSOX icon
348
AdvisorShares MSOS 2X Daily ETF
MSOX
$58.7M
$89K 0.03%
20,000
-6,452
-24% -$37.7K
SEI
349
Solaris Energy Infrastructure
SEI
$3.94B
$89K 0.03%
1,944
-5,446
-74% -$263K
FXY icon
350
Invesco CurrencyShares Japanese Yen Trust
FXY
$426M
$88K 0.02%
+1,500
New +$89.5K
12 13
14
15 16

Similar funds

ACP
Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $279M AUM 45.74% 1-Year Est. Return
SL
SOF Ltd George Town, Cayman Islands $279M AUM 6.12% 1-Year Est. Return
BCH
Berkshire Capital Holdings San Jose, California $277M AUM 190.28% 1-Year Est. Return
NCM
NCM Capital Management Ramsey, New Jersey $279M AUM 26.47% 1-Year Est. Return
RFA
Resurgent Financial Advisors Atlanta, Georgia $277M AUM 21.5% 1-Year Est. Return
HCM
Hall Capital Management Barrington, Rhode Island $280M AUM 14.82% 1-Year Est. Return
EFP
Envision Financial Planning Memphis, Tennessee $276M AUM 10.87% 1-Year Est. Return

FNY Investment Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, FNY Investment Advisers held 1,674 positions worth $354M, up 14% from $311M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

FNY Investment Advisers deployed $30.3M of net new capital in Q4 2025, opening 354 new positions and adding to 213 existing holdings. Its largest new stake was Cidara Therapeutics: 145,533 shares worth $32.1M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 12% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Sibanye-Stillwater, an estimated $4.39M trimmed.

  • FNY Investment Advisers's largest Q4 2025 buy was Cidara Therapeutics: 145,533 shares worth $32.1M.
  • FNY Investment Advisers added most to Morgan Stanley in Q4 2025, an estimated $6.17M increase.
  • FNY Investment Advisers's biggest Q4 2025 reduction was Sibanye-Stillwater, cutting an estimated $4.39M.
  • FNY Investment Advisers fully exited Verona Pharma in Q4 2025, selling an estimated $15.8M.
  • FNY Investment Advisers's ten largest holdings make up 32% of its $354M portfolio in Q4 2025.
  • FNY Investment Advisers opened 354 new positions and closed 746 in Q4 2025.
  • FNY Investment Advisers's portfolio value rose 14% quarter-over-quarter to $354M.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.